Open Access

Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents

  • Wei-fen Zhu1,
  • Chun-lin Wang1,
  • Li Liang1Email author,
  • Zheng Shen2,
  • Jun-fen Fu3,
  • Pei-ning Liu4,
  • Lan-qiu Lv5 and
  • Yi-min Zhu6
Lipids in Health and Disease201413:93

DOI: 10.1186/1476-511X-13-93

Received: 17 February 2014

Accepted: 2 June 2014

Published: 5 June 2014

Abstract

Background

Although the association between the apolipoprotein A5 (APOA5) genetic variants and hypertriglyceridemia has been extensively studied, there have been few studies, particularly in children and adolescents, on the association between APOA5 genetic variants and obesity or non-high-density lipoprotein cholesterol (non-HDL-C) levels. The objective of this study was to examine whether APOA5 gene polymorphisms affect body mass index (BMI) or plasma non-HDL-C levels in Chinese child population.

Methods

This was a case–control study. Single nucleotide polymorphisms (SNPs) were genotyped using Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry for an association study in 569 obese or overweight and 194 healthy Chinese children and adolescents.

Results

Genotype distributions for all polymorphisms in both cohorts were in accordance with the Hardy-Weinberg distribution. The frequencies of the risk alleles in rs662799 and rs651821 SNPs in APOA5 gene were all increased in obese or overweight patients compared to the controls. After adjusted for age and sex, C carriers in rs662799 had a 1.496-fold [95% confidence interval (CI): 1.074-2.084, P = 0.017] higher risk for developing obesity or overweight than subjects with TT genotype, while C carriers in rs651821 had a 1.515-fold higher risk than subjects with TT genotype (95% CI: 1.088-2.100, P = 0.014). Triglyceride (TG) and non-HDL-C concentrations were significantly different among rs662799 variants and both were higher in carriers of minor allele than in noncarriers for TG (1.64 ± 0.96 vs. 1.33 ± 0.67 mmol/L) (P < 0.001), and for non-HDL-C (3.23 ± 0.92 vs. 3.02 ± 0.80 mmol/L) (P = 0.005), respectively. There was also a trend towards increased TG and non-high-density lipoprotein cholesterol levels for rs651821 C carriers (P < 0.001 and P = 0.002, respectively). Furthermore, to confirm the independence of the associations between APOA5 gene and TG or non-HDL-C levels, multiple linear regression analysis was performed and the relationships were not eliminated by adjustment for age, sex and BMI.

Conclusions

These findings suggest the TG-raising genetic variants in the APOA5 gene may influence the susceptibility of the individual to obesity, which may also contribute to an increased risk of high non-HDL-C levels in Chinese obese children and adolescents.

Keywords

Apolipoprotein A5 Obesity Dyslipidemia Children

Background

Obesity is one of the most complex clinical syndromes facing children, almost one-third of obese children remain obese in adulthood and that the risk of obesity as an adult was close to twice as high for obese children compared with those who had the normal weight during the growing period [1]. One of the most deleterious metabolic disorders of obesity is dyslipidemia, which is frequently occured and highly atherogenic. Recently, there is a growing consensus that non-high-density lipoprotein cholesterol (non-HDL-C), an indicator of dyslipidemia, appears to be more predictive of persistent dyslipidemia than total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) or high density lipoprotein cholesterol (HDL-C) for children [2]. In 2011, Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents released its summary report, which recommends non-HDL-C as a predictor of cardiovascular disease risk [3]. It appears that health professionals shall give more attention on non-HDL-C for a better care of children and adolescents, especially obese individuals.

In children and adolescents, the effects of environmental factors such as smoking, drinking and exercise are considerably weaker than in adults. According to the previous work the heritability of obesity in infancy is 60-80% and is reported to be 77% in preadolescents [4, 5]. Therefore, it is crucial to investigate the genetic contribution to obesity and obesity-associated metabolic abnormalities, permitting screening and preventive treatment for obese children and adolescents. Many researchers have discovered multiple commonvariations that may give rise to genetic susceptibility of common childhood obesity, such as fat mass and obesity associated gene, melanocortin 4 receptor gene, glucosamine-6-phosphate deaminase 2 and so on [68]. Apolipoprotein A5 (APOA5) gene, located on chromosome 11 adjacent to APOA1/APOC3/APOA4 gene cluster with known functions in the metabolism of plasma lipids [9], also modulates the risk of obesity in a number of studies [1012]. However, in Chinese children and adolescents, limited data are available about the effect of APOA5 variants on childhood obesity and obesity-associated dyslipidemia such as elevated non-HDL-C levels. To detect additional common variants associated with obesity and non-HDL-C in Chinese child population, we conducted this multicenter study.

Results

The demographic variables and laboratory data of cases (569 obese or overweight children) and controls (194 healthy individuals) are presented in Table 1. As expected, there were no differences for the matching criteria of age and sex between the two cohorts. Compared with data of control group, obese or overweight group had significantly elevated body mass index (BMI) z-score, TC, triglyceride (TG), LDL-C, non-HDL-C levels and lower HDL-C levels (all P < 0.001).
Table 1

Demographic and metabolic characteristics of the study participants

 

Control group (n = 194)

Obese or over-weight group (n = 569)

P

Sex (M/F)

149/45

417/152

0.252

Age (years)

10.94 ± 2.78

10.76 ± 2.02

0.410

BMI z-scores

(-0.27) ± 0.52

3.19 ± 1.38

<0.001

SBP (mmHg)

93.9 ± 11.27

112.45 ± 14.46

<0.001

DBP (mmHg)

66.35 ± 7.64

68.50 ± 9.09

0.001

TC (mmol/L)

3.80 ± 0.51

4.37 ± 0.92

<0.001

TG (mmol/L)

0.77 ± 0.32

1.49 ± 0.85

<0.001

HDL-C (mmol/L)

1.50 ± 0.31

1.25 ± 0.31

<0.001

LDL-C (mmol/L)

1.94 ± 0.41

2.56 ± 0.71

<0.001

non-HDL-C (mmol/L)

2.30 ± 0.43

3.14 ± 0.87

<0.001

FPG

4.84 ± 0.48

5.06 ± 0.65

<0.001

BMI, Body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure, TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Non-HDL-C, non-high-density lipoprotein cholesterol; FPG, fasting plasma glucose.

Overall, rs662799 and rs651821 SNPs were selected and genotyped in the present study. Genotype distributions for all polymorphisms in both cohorts were in accordance with the Hardy-Weinberg distribution (data not shown). The prevalence of rs662799 C allelic variant in APOA5 gene was significantly elevated in obese or overweight group compared with control group (30.3% vs 23.7%, P = 0.013). Meanwhile, a significant elevation was observed in frequency of risk C allele in rs651821 for obese or overweight group (30.4% versus 24.0% for controls, P = 0.016). Table 2 shows the genotype distribution of the two polymorphisms in case and control population. Frequencies of the TT, TC, and CC genotypes in rs662799 were 48.8%, 41.9% and 9.3% in obese or overweight group, and 58.8%, 35.0% and 6.2% in control group, respectively, which were statistically different between the two groups (P = 0.047). Additionally, Frequencies of the TT, CT, and CC genotypes in rs651821 were also significantly different between obese or overweight group and control group (P = 0.048).
Table 2

Distribution of genotypes for APOA5 SNPs in cases and controls

Gene

SNP

Genotype

Control group

Obese or overweight group

P

APOA5

rs662799

TT

114 (58.8%)

277 (48.8%)

0.047

  

TC

68 (35.0%)

238 (41.9%)

 
  

CC

12 (6.2%)

53 (9.3%)

 

APOA5

rs651821

TT

113 (58.2%)

274 (48.2%)

0.048

  

CT

69 (35.6%)

243 (42.8%)

 
  

CC

12 (6.2%)

51 (9.0%)

 
We then employed logistic regression to test the effect of the two APOA5 SNPs on the risk of obesity, the results of which are presented in Table 3. Carriers of the C allele (CC + TC) in rs662799 had a 1.471-fold higher risk for developing obesity or overweight [odd ratio (OR) =1.471, 95% confidence interval (CI): 1.058-2.046, P = 0.022] than subjects with TT genotype, while carriers of the C allele (CC + TC) in rs651821 had a 1.486-fold higher risk than subjects with TT genotype (OR = 1.486, 95% CI: 1.069-2.066, P = 0.018). These associations remained significant after controlling for age and sex (rs662799: adjusted OR 1.496, 95% CI 1.074-2.084, P = 0.017; rs651821: adjusted OR 1.515, 95% CI 1.088-2.110, P = 0.014).
Table 3

OR for obese or overweight associated with minor allele of each SNP at APOA5 gene

SNP

Genotype

OR (95% CI)

P value

Adjusted ORa(95% CI)

P value

rs662799

TT

1

 

1

 
 

CC + TC

1.471 (1.058-2.046)

0.022

1.496 (1.074-2.084)

0.017

rs651821

TT

1

 

1

 
 

CC + TC

1.486 (1.069-2.066)

0.018

1.515 (1.088-2.110)

0.014

OR, odds ratio; CI, confidence intervals.

aAdjusted for sex and age.

Next, the association between APOA5 variants and obesity-related traits in obese or overweight children were examined. Figure 1 presents the changes in TG and non-HDL-C levels depending on the rs662799 and rs651821 polymorphism. Our results provided direct evidence for an association between the APOA5 polymorphism and TG levels in Chinese children and adolescents. Also, non-HDL-C was influenced significantly by APOA5 gene variants. We noted that the non-HDL-C in obese or overweight children with non-TT (CC + TC) genotype was 3.23 ± 0.92 mmol/L, which was elevated than that in obese children with TT genotype in rs662799 (3.02 ± 0.80 mmol/L) with a significant difference (P = 0.005). There was also a significant trend towards increased non-HDL-C levels for APOA5 rs651821 C carriers (TT genotype: 3.01 ± 0.80 mmol/L; non-TT genotype: 3.24 ± 0.92 mmol/L; P = 0.002).
https://static-content.springer.com/image/art%3A10.1186%2F1476-511X-13-93/MediaObjects/12944_2014_Article_1083_Fig1_HTML.jpg
Figure 1

Lipid profiles according to APOA5 rs662799 and rs651821 genotypes in obese or overweight children. TG (black bar), non-HDL-C (gray bar). Results are expressed as mean ± SD and significant difference: *P < 0.05 non-risk genotypes vs risk genotypes (TG levels); +P < 0.05 non-risk genotypes vs risk genotypes (non-HDL-C levels).

To confirm the independence of the associations between APOA5 gene polymorphisms and TG or non-HDL-C levels, multiple linear regression models, using transformed log-TG as the dependent variable and including both APOA5 rs662799 and rs651821 variants and other lipid influencing factors (age, sex, BMI) as the covariates, were performed in obese or overweight children. Carriership for APOA5 rs662799 risk allele was identified as a significant and independent predictor of both TG (standardized β-coefficient = 0.184; p < 0.001) and non-HDL-C variabilities (standardized β-coefficient = 0.179; p < 0.001). Similarly, carriership for APOA5 rs661821 risk allele was a significant and independent predictor for both TG (standardized β-coefficient = 0.120; p = 0.004) and non-HDL-C variabilities (standardized β-coefficient = 0.132; p = 0.002) (Table 4).
Table 4

APOA5 variant carriership in multiple linear regressions with TG or non-HDL-C as the dependent variable in obese or overweight subjects

 

B

95% CI for B

Standardized β-coefficient

P

TG

    

Carrier of APOA5 rs662799 C allele

0.275

0.154-0.397

0.184

<0.001

Carrier of APOA5 rs651821 C allele

0.304

0.166-0.441

0.179

<0.001

Non-HDL-C

    

Carrier of APOA5 rs662799 C allele

0.208

0.065-0.350

0.120

0.004

Carrier of APOA5 rs651821 C allele

0.231

0.088-0.374

0.132

0.002

TG, triglyceride; Non-HDL-C, non-high-density lipoprotein cholesterol; CI, confidence intervals.

Log-transformed TG was used as the dependent variable; covariates included APOA5 polymorphisms, age, sex and BMI.

Discussion

The rising healthcare costs of obesity and obesity-associated health problems are sufficient to justify prevention as daily work of the pediatric clinicians. By recognizing genetic variants that predispose to obesity, pediatricians could classify obese children into subgroups that might respond to specific diets or physical activity regimes, drugs or surgeries. In this study, we selected the most extensively studied SNP in APOA5 gene, tag SNP rs662799 in the promoter region and another SNP rs651821, located 3 bp upstream from the predicted start codon of APOA5, which is in linkage disequilibrium with the much studied rs662799. The two tightly linked SNPs both show high minor allele frequencies in Chinese population, our results may be generalizable to other ethnic child population which have similar minor allele frequencies.

Our available data supported the hypothesis that the TG-raising genetic variants in the APOA5 gene may also have high risks for obesity in Chinese children and adolescents. In consistent with our results, Horvatovich et al. revealed that APOA5*2 haplotype (containing the minor alleles of rs662799, rs2072560 and rs2266788) confers susceptibility to development of obesity in pediatric patients [13]. Additionally, in Aberle’s study, at baseline, TT homozygotes had a lower BMI compared to carriers of the C allele, although without a statistical significance [14]. Until now much is learned about the biologic function of APOA5, however, little is known about the associations between APOA5 variants and body fat composition. Thus, mechanisms underlying our findings still remain hypothetic, requiring further work to prove. One speculated mechanism is that the effect of APOA5 gene variants on the risk of obesity might be attributed to this locus being in interaction with other obesity-risk genes, such as APOA1, APOC3 and APOA4 genes [15, 16]. Since the APOA1/C3/A4/A5 cluster occupies a restricted chromosomal region, phenotypic effects that appear to result from mutations in one member of the cluster might actually derive from allelic associations with functional variants in another [17]. Other potential mechanisms could be linked to lipoprotein lipase (LPL) activation by the variable effects from multiple novel APOA5 variants, resulting in varying degrees of impaired lipolysis [18]. As obesity is a complex, multifactorial condition for which heritability estimates vary widely. It might be the case in the association of obesity with APOA5 gene variants, as a result, further studies are needed to clarify this issue.

Although the association between APOA5 genetic variants and hypertriglyceridemia has been extensively studied [1921] and also replicated in our study, there have been few studies, particularly in children and adolescents, on the association between APOA5 genetic variants and non-HDL-C levels. Furthermore, the relationships for TG or non-HDL-C were not eliminated by adjustment for age, sex and BMI, suggesting that this genetic factors act independently of age, sex or BMI. In consistent with our results, Hubacek et al. also suggested that the rs662799 variant in the APOA5 gene could be a significant genetic determinant for plasma non-HDL-C levels [22]. So far as we know, there are scarce studies to provide some mechanism by which APOA5 gene variants could affect non-HDL-C levels. It is known that APOA5 protein accelerates plasma hydrolysis of TG-rich lipoproteins by activation of plasma LPL [23]. We speculate that abnormalities in LPL activity could directly lead to delayed hydrolysis of TG-rich lipoproteins and elevated levels of intermediate metabolites in plasma, such as intermediate density lipoprotein (IDL), VLDL and chylomicrons, which resulted in an elevation of plasma non-HDL-C levels. Certainly, the detailed description of this hypothetic mechanismis needed for more intensive investigation.

The current study has several limitations that should be noted. First, the interactions between gene-gene, gene-environment and even different polymorphic loci of the same gene may influence the biological effects of the polymorphisms of the genes. Second, for all the polymorphisms, the number of the available studies in some subgroups, such as the control group was small. Third, due to the cross-sectional nature of the study design, the causal relationships between gene variants and clinical disorders can’t be drawn. Thus, we hope to perform full longitudinal association analyses in larger samples and more candidate genes in the future prospective studies. Furthermore, studies in the other populations will be useful to confirm our results.

Conclusions

In conclusion, we herein demonstrated the TG-raising genetic variants in the APOA5 gene may influence the susceptibility of the individual to obesity, which may also contribute to an increased risk of high non-HDL-C levels in Chinese obese children and adolescents. We believe that our findings will improve the understanding of biological functions of APOA5 gene variants.

Methods and procedures

Study population

This case–control study was conducted from 2011to 2012. We totally recruited 569 obese or overweight patients (“case”) at the age of 7–16 from outpatients who visited one of the following three medical centers for their weight problems: (1) Department of Endocrinology, Children’s Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang; (2) Department of Child Health Care, the Affiliated Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang; (3) Department of Child Health Care, Ningbo Women & Children’s Hospital, Ningbo, Zhejiang. According to the diagnostic criteria developed by the Working Group for Obesity Task Force in China [24], the 85th and the 95th percentiles of age- and sex-specific BMI were used as cut-off points for defining overweight and obesity, respectively. In addition, we recruited 194 healthy children (“control”) who were ascertained at the Department of Child Health Care, Children Hospital of Zhejiang University School of Medicine. Exclusion criteria for the controls consisted of the known presence of diabetes, hypertension, dyslipidaemia, other endocrine metabolic or kidney diseases and the use of medications that altered blood pressure, glucose, or lipid metabolism.

Informed consent was obtained from the parents, and approved by the ethics committee of all the aforementioned three medical centers: the Children Hospital of Zhejiang University School of Medicine, the Affiliated Yuying Children’s Hospital of Wenzhou Medical University and Ningbo Women & Children’s Hospital.

Physical parameters

Body height was measured to the nearest 0.1 cm, while weight was measured to the nearest 0.1 kg. At the time the measurements were made, the participants were only their underwear. BMI was calculated as body weight (kg) divided by the square of body height (m2). Age- and sex-specific BMI z-scores were used as continuous dependant variables for each model [25].

Biochemical parameters

Baseline blood samples were obtained early in the morining after an overnight fast and immediately measured. Serum TC and TG were determined with an enzymatic colorimetric. Serum HDL-C and LDL-C were measured through a direct assay. All biochemical parameters were measured in a conventional automated analyzer (BECKMAN Synchron Clinical System CX4, American). Non-HDL-C was calculated as TC level minus HDL-C. The remaining blood samples were stored at -80 degrees Celsius for SNP genotyping.

SNP genotyping

DNA was isolated from blood samples using Blood Genomic DNA Miniprep Kit (AxyPrep) according to the protocol of the manufacturer. All samples were originally genotyped using an automated platform MassARRAY (Sequenom, San Diego, CA).

DNA sequence containing the target SNP site was first amplified by polymerase chain reaction. By using the SNP specific primers, the products were extended one base in SNP sites. After applied into the MassARRAY SpectroCHIP array, the products were crystallized with matrix in the chip. And then the crystal containing chip was directed into the mass spectrometer vacuum tube and excited using an instantaneous nanosecond (10–9 s) laser. The molecular of matrix absorb the laser radiation, which resulted in energy accumulation causing crystal matrix sublimation, DNA molecule desorption and transformation to metastable ions [26].

Statistical analysis

Quantitative variables were expressed as mean ± standard deviation (SD) and differences between groups were calculated by Student’s t-test. The chi-square test was employed to test for deviations of the genotypes from the Hardy-Weinberg equilibrium and to evaluate categorical variables. To determine whether SNP polymorphisms were independent modulators on the development of obesity, logistic regression analysis was performed adjusted for age and sex. We applied ANOVA and the Studens’s t test to compare crude means across genotype groups. A multiple linear regression models procedure was performed by using transformed log-TG as the dependent variable, and including carrierships of APOA5 variants and other influencing factors (age, sex, BMI) as the covariates. The power calculation was performed using Quanto software (http://hydra.usc.edu/gxe/). Our study had ≥68.1% to ≥98.5% power (enrolment of 569 cases and 194 controls) to detect Ors of 1.50 to 2.00 for obesity under an additive model, assuming a significance of 0.05, an allele frequency of 0.267, and overweight or obesity prevalence of 19.9% in 7- to 16- year old Chinese Children [27]. Statistical analysis was performed using SPSS 17.0 software, and two tailed P-value <0.05 was considered statistically significant.

Authors’ information

We all agree that every author is the co-first author of the paper.

Abbreviations

non-HDL-C: 

Non-high-density lipoprotein cholesterol

TC: 

Total cholesterol

LDL-C: 

Low-density lipoprotein cholesterol

HDL-C: 

High density lipoprotein cholesterol

APOA5: 

Apolipoprotein A5

BMI: 

Body mass index

TG: 

Triglyceride

OR: 

Odd ratio

CI: 

Confidence interval

LPL: 

Lipoprotein lipase.

Declarations

Acknowledgements

We sincerely thank the parents and children for participating in this study. Thanks for the language corrections by Dr. Tongzhou Xu from the University of California, Los Angeles. This study was supported by Zhejiang Provincial Natural Science Foundation of China (Y2090137) and the National Natural Science Foundation of China (Grant No. 81000267).

Authors’ Affiliations

(1)
Department of Pediatrics, The First Affiliated Hospital, College of Medicine, Zhejiang University
(2)
Department of Central Laboratory, Children’s Hospital of Zhejiang University School of Medicine
(3)
Department of Endocrinology, Children’s Hospital of Zhejiang University School of Medicine
(4)
Department of Child Health Care, The Affiliated Yuying Children’s Hospital of Wenzhou Medical University
(5)
Department of Child Health Care, Ningbo Women & Children’s Hospital
(6)
Department of Epidemiology & Biostatistics, Zhejiang University School of Public Health

References

  1. Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T: Do obese children become obese adults? A review of the literature. Prev Med. 1993, 22: 167-177. 10.1006/pmed.1993.1014View ArticlePubMedGoogle Scholar
  2. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS: Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics. 2001, 108: 712-718. 10.1542/peds.108.3.712View ArticlePubMedGoogle Scholar
  3. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institue: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011, 128: S213-S256.PubMed CentralView ArticleGoogle Scholar
  4. Demerath EW, Choh AC, Czerwinski SA, Lee M, Sun SS, Chumlea WC, Duren D, Sherwood RJ, Blangero J, Towne B, Siervogel RM: Genetic and environmental influences on infant weight and weight change: the Fels Longitudinal Study. Am J Hum Biol. 2007, 19: 692-702. 10.1002/ajhb.20660PubMed CentralView ArticlePubMedGoogle Scholar
  5. Wardle J, Carnell S, Haworth CM, Plomin R: Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr. 2008, 87: 398-404.PubMedGoogle Scholar
  6. Dina C, Meyre D, Gallina S, Durand E, Körner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C, Delplanque J, Vaillant E, Pattou F, Ruiz J, Weill J, Levy-Marchal C, Horber F, Potoczna N, Hercberg S, Le Stunff C, Bougnères P, Kovacs P, Marre M, Balkau B, Cauchi S, Chèvre JC, Froguel P: Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007, 39: 724-726. 10.1038/ng2048View ArticlePubMedGoogle Scholar
  7. Wu L, Xi B, Zhang M, Shen Y, Zhao X, Cheng H, Hou D, Sun D, Ott J, Wang X, Mi J: Associations of six single nucleotide polymorphisms in obesity-related genes with BMI and risk of obesity in Chinese children. Diabetes. 2010, 59: 3085-3089. 10.2337/db10-0273PubMed CentralView ArticlePubMedGoogle Scholar
  8. Comuzzie AG, Cole SA, Laston SL, Voruganti VS, Haack K, Gibbs RA, Butte NF: Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One. 2012, 7: e51954- 10.1371/journal.pone.0051954PubMed CentralView ArticlePubMedGoogle Scholar
  9. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001, 294: 169-173. 10.1126/science.1064852View ArticlePubMedGoogle Scholar
  10. Hsu MC, Chang CS, Lee KT, Sun HY, Tsai YS, Kuo PH, Young KC, Wu CH: Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster. Nutr Diabetes. 2013, 3: e61- 10.1038/nutd.2013.2PubMed CentralView ArticlePubMedGoogle Scholar
  11. Wu CK, Chang YC, Hua SC, Wu HY, Lee WJ, Chiang FT, Hwang JJ, Lien WP, Chuang LM: A triglyceride-raising APOA5 genetic variant is negatively associated with obesity and BMI in the Chinese population. Obesity. 2010, 18: 1964-1968. 10.1038/oby.2010.10View ArticlePubMedGoogle Scholar
  12. Chen ES, Furuya TK, Mazzotti DR, Ota VK, Cendoroglo MS, Ramos LR, Araujo LQ, Burbano RR, de Arruda Cardoso Smith M: APOA1/A5 variants and haplotypes as a risk factor for obesity and better lipid profiles in a Brazilian Elderly Cohort. Lipids. 2010, 45: 511-517. 10.1007/s11745-010-3426-zView ArticlePubMedGoogle Scholar
  13. Horvatovich K, Bokor S, Baráth A, Maász A, Kisfali P, Járomi L, Polgár N, Tóth D, Répásy J, Endreffy E, Molnár D, Melegh B: Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients. Int J Pediatr Obes. 2011, 6: e318-e325. 10.3109/17477166.2010.490268View ArticlePubMedGoogle Scholar
  14. Aberle J, Evans D, Beil FU, Seedorf U: A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet. Clin Genet. 2005, 88: 152-154.View ArticleGoogle Scholar
  15. Chen ES, Mazzotti DR, Furuya TK, Cendoroglo MS, Ramos LR, Araujo LQ, Burbano RR, de Arruda Cardoso Smith M: Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity. Clin Exp Med. 2009, 9: 319-325. 10.1007/s10238-009-0051-3View ArticlePubMedGoogle Scholar
  16. Fisher RM, Burke H, Nicaud V, Ehnholm C, Humphries SE: Effect of variation in the apoa A-IV gene on body mass index and postprandial lipids in the European Atherosclerosis Reasearch StudyII. EARS Group. J Lipid Res. 1999, 40: 287-294.PubMedGoogle Scholar
  17. Hallman DM, Srinivasan SR, Chen W, Boerwinkle E, Berenson GS: Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Metabolism. 2006, 55: 1574-1581. 10.1016/j.metabol.2006.07.018View ArticlePubMedGoogle Scholar
  18. Dorfmeister B, Zeng WW, Dichlberger A, Nilsson SK, Schaap FG, Hubacek JA, Merkel M, Cooper JA, Lookene A, Putt W, Whittall R, Lee PJ, Lins L, Delsaux N, Nierman M, Kuivenhoven JA, Kastelein JJ, Vrablik M, Olivecrona G, Schneider WJ, Heeren J, Humphries SE, Talmud PJ: Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. Arterioscler Thromb Vasc Biol. 2008, 28: 1866-1871. 10.1161/ATVBAHA.108.172866View ArticlePubMedGoogle Scholar
  19. Endo K, Yanaqi H, Araki J, Hirano C, Yamakawa-Kobayashi K, Tomura S: Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet. 2002, 111: 570-572. 10.1007/s00439-002-0825-0View ArticlePubMedGoogle Scholar
  20. Guardiola M, Ribalta J, Gómez-Coronado D, Lasunción MA, De Oya M, Garcés C: The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study). Atherosclerosis. 2010, 212: 543-547. 10.1016/j.atherosclerosis.2010.07.004View ArticlePubMedGoogle Scholar
  21. Klos KL, Hamon S, Clark AG, Boerwinkle E, Liu K, Sing CF: APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study. J Lipid Res. 2005, 46: 564-571.View ArticlePubMedGoogle Scholar
  22. Hubacek JA, Skodová Z, Lánská V, Adámková V: Apolipoprotein A-V variant (T-1131 > C) affects plasmal level of non-high-density lipoprotein cholesterol in Caucasians. Exp Clin Cardiol. 2008, 13: 129-132.PubMed CentralPubMedGoogle Scholar
  23. Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J: Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem. 2005, 280: 21553-21560. 10.1074/jbc.M411412200View ArticlePubMedGoogle Scholar
  24. Group of China Obesity Task Force: Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents. Zhonghua Liu Xing Bing Xue Za Zhi. 2004, 25: 97-102.Google Scholar
  25. Chen XF, Liang L, Fu JF, Gong CX, Xiong F, Liu GL, Luo FH, Chen SK: Study on physique index set for Chinese children and adolescents. Zhonghua Liu Xing Bing Za Zhi. 2012, 33: 449-454.Google Scholar
  26. Zou CC, Huang K, Liang L, Zhao ZY: Polymorphisms of the ghrelin/obestatin gene and ghrelin levels in Chinese children with short stature. Clin Endocrinol (Oxf). 2008, 69: 99-104. 10.1111/j.1365-2265.2007.03171.xView ArticleGoogle Scholar
  27. Chinese Work Group of Pediatric Metabolic Syndrome: Prevalence of metabolic syndrome of children and adolescent students in Chinese six cities. Zhonghua Er Ke Za Zhi. 2013, 51: 409-413.Google Scholar

Copyright

© Zhu et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.